These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22554205)

  • 21. [Systane and cataract surgery].
    Stefan C; Dumitrica DM
    Oftalmologia; 2007; 51(4):100-4. PubMed ID: 18543684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a fixed combination of 0.09 % xanthan gum/0.1 % chondroitin sulfate preservative free vs polyethylene glycol/propylene glycol in subjects with dry eye disease: a multicenter randomized controlled trial.
    Pérez-Balbuena AL; Ochoa-Tabares JC; Belalcazar-Rey S; Urzúa-Salinas C; Saucedo-Rodríguez LR; Velasco-Ramos R; Suárez-Sánchez RG; Rodríguez-Carrizalez AD; Oregón-Miranda AA
    BMC Ophthalmol; 2016 Sep; 16(1):164. PubMed ID: 27645318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study.
    Prabhasawat P; Tesavibul N; Kasetsuwan N
    Br J Ophthalmol; 2007 Jan; 91(1):47-50. PubMed ID: 16973668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye.
    Johnson ME; Murphy PJ; Boulton M
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):109-12. PubMed ID: 15983814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of different lubricant eye gels on tear film thickness as measured with ultrahigh-resolution optical coherence tomography.
    Wozniak PA; Schmidl D; Bata AM; Fondi K; Witkowska KJ; Aranha Dos Santos V; Baar C; Room KI; Nepp J; Baumgartner I; Popa-Cherecheanu A; Garhöfer G; Werkmeister RM; Schmetterer L
    Acta Ophthalmol; 2017 Jun; 95(4):e307-e313. PubMed ID: 27989018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel ocular lubricant containing an intelligent delivery system: details of its mechanism of action.
    Springs C
    Dev Ophthalmol; 2010; 45():139-147. PubMed ID: 20502034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population.
    Hartstein I; Khwarg S; Przydryga J
    Curr Med Res Opin; 2005 Feb; 21(2):255-60. PubMed ID: 15801996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial.
    Asbell P; Vingrys AJ; Tan J; Ogundele A; Downie LE; Jerkins G; Shettle L
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2275-2280. PubMed ID: 29715369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of artificial tears on visual performance in subjects with dry eye.
    Ridder WH; Tomlinson A; Paugh J
    Optom Vis Sci; 2005 Sep; 82(9):835-42. PubMed ID: 16189494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
    Liu Z; Pflugfelder SC
    Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular tolerability and efficacy of a cationic emulsion in patients with mild to moderate dry eye disease - a randomised comparative study.
    Amrane M; Creuzot-Garcher C; Robert PY; Ismail D; Garrigue JS; Pisella PJ; Baudouin C
    J Fr Ophtalmol; 2014 Oct; 37(8):589-98. PubMed ID: 25127703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrasubject tear osmolarity changes with two different types of eyedrops.
    Montani G
    Optom Vis Sci; 2013 Apr; 90(4):372-7. PubMed ID: 23507972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical evaluation of Systane.
    Gifford P; Evans BJ; Morris J
    Cont Lens Anterior Eye; 2006 Mar; 29(1):31-40. PubMed ID: 16473547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease.
    Schmidl D; Schmetterer L; Witkowska KJ; Unterhuber A; dos Santos VA; Kaya S; Nepp J; Baar C; Rosner P; Werkmeister RM; Garhofer G
    Cornea; 2015 Apr; 34(4):421-6. PubMed ID: 25651494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of dry eye therapy under conditions of environmental stress.
    Tomlinson A; Madden LC; Simmons PA
    Curr Eye Res; 2013 Feb; 38(2):229-36. PubMed ID: 23294168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An evaluation of the efficacy of a cyclosporine-based dry eye therapy when used with marketed artificial tears as supportive therapy in dry eye.
    Sall KN; Cohen SM; Christensen MT; Stein JM
    Eye Contact Lens; 2006 Jan; 32(1):21-6. PubMed ID: 16415689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose.
    Cohen S; Martin A; Sall K
    Clin Ophthalmol; 2014; 8():157-64. PubMed ID: 24403819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
    Mun Y; Kwon JW; Oh JY
    BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relieving the symptoms of dry eye disease: update on lubricating eye drops containing hydroxypropyl-guar.
    Garofalo R; Kunnen C; Rangarajan R; Manoj V; Ketelson H
    Clin Exp Optom; 2021 Nov; 104(8):826-834. PubMed ID: 34137675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.